Nexus (ETR:NXU) Second Quarter 2024 Results
Key Financial Results
- Revenue: €67.0m (up 16% from 2Q 2023).
- Net income: €5.83m (up 13% from 2Q 2023).
- Profit margin: 8.7% (down from 9.0% in 2Q 2023). The decrease in margin was driven by higher expenses.
- EPS: €0.34 (up from €0.30 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nexus Earnings Insights
Looking ahead, revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
Performance of the market in Germany.
The company's share price is broadly unchanged from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Nexus' balance sheet.
Valuation is complex, but we're here to simplify it.
Discover if Nexus might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About XTRA:NXU
Nexus
Develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally.
Flawless balance sheet with solid track record.